Allstate Corp Neurocrine Biosciences Inc Transaction History

Allstate Corp

$3.33 Billion
Q1 2025

A detailed history of Allstate Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Allstate Corp holds 4,930 shares of NBIX stock, worth $615,116. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,930

Previous 2,909 69.47%

Holding current value

$615,116

Previous $397,000 37.28%

% of portfolio

0.02%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$107.22 - $153.29 $216,691 - $309,799	2,021 Added 69.47%	4,930 $545,000
Q4 2024 Feb 12, 2025	BUY	$111.62 - $139.44 $324,702 - $405,630	2,909 New	2,909 $397,000
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $106 - $127	1 Added 0.02%	4,215 $503,000
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $57,334 - $67,165	623 Added 17.35%	4,214 $448,000
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $272,161 - $359,351	3,591 New	3,591 $350,000
Q4 2021 Feb 15, 2022	SELL	$79.65 - $106.22 $280,527 - $374,106	-3,522 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $23,354 - $26,837	-271 Reduced 7.14%	3,522 $338,000
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $22,357 - $25,567	250 Added 7.06%	3,793 $369,000
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $105,171 - $143,399	-1,201 Reduced 25.32%	3,543 $345,000
Q4 2020 Feb 12, 2021	BUY	$86.91 - $108.33 $114,981 - $143,320	1,323 Added 38.67%	4,744 $455,000
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $56,926 - $80,008	-592 Reduced 14.75%	3,421 $329,000
Q2 2020 Aug 13, 2020	SELL	$85.09 - $130.36 $14,635 - $22,421	-172 Reduced 4.11%	4,013 $490,000
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $660,968 - $1 Million	-8,800 Reduced 67.77%	4,185 $362,000
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $17,602 - $21,315	210 Added 1.64%	12,985 $1.17 Million
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $922,865 - $1.17 Million	12,775 New	12,775 $1.08 Million

Others Institutions Holding NBIX

# of Institutions

649

Shares Held

97.1M

Call Options Held

749K

Put Options Held

553K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Account